Write For Us

US approves controversial new Alzheimer’s drug

Sponsored Post Vitamin D2 Canada Persia
76 Views
Published
US government health regulators have approved the first medication called aducanumab to treat Alzheimer’s disease in nearly two decades.
Its makers say it reduces fatty plaque in the brain which is the main reason for mental decline.
But independent experts say more studies on the drug need to be done as results are so far inconclusive.

Al Jazeera’s Rob Reynolds reports.

- Follow us on Twitter: https://twitter.com/AJEnglish/
- Find us on Facebook: https://www.facebook.com/aljazeera/
- Check our website: https://www.aljazeera.com/

#Alzheimers #Aducanumab #Biogen
Category
World
Tags
Aducanumab, Aljazeera, Alzheimer disease
Sign in or sign up to post comments.
Be the first to comment